je.st
news
MacroGenics, Inc. Presents Phase 1 Data at American Society of...
2013-06-04 21:14:32| Logistics - Topix.net
Howard A. Burris, M.D., FACP, first author and Chief Medical Officer of Sarah Cannon Research Institute, presented "Phase 1 study of margetuximab , an Fc-modified chimeric monoclonal antibody , in patients with advanced solid tumors expressing the HER2 oncoprotein," during the Developmental Therapeutics - Immunotherapy Oral Abstract Session .
Tags: of
data
american
society
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||